Health Care & Life Sciences » Pharmaceuticals | Jaguar Animal Health Inc.

Jaguar Animal Health Inc. | Ownership

Companies that own Jaguar Animal Health Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Invesco Asset Management Ltd.
1,792,389
18.8%
-9
0%
06/30/2018
Kingdon Capital Management LLC
343,256
3.6%
-3
0.03%
06/30/2018
JMG Capital Management LLC
105,548
1.11%
105,548
0.76%
07/18/2018
Acadian Asset Management LLC
99,557
1.05%
99,557
0%
06/30/2018
Howard Capital Management, Inc. (California)
49,999
0.53%
16,665
0.01%
06/30/2018
AlphaNorth Asset Management
33,334
0.35%
33,334
0.34%
12/31/2017
Geode Capital Management LLC
29,930
0.31%
-1
0%
06/30/2018
G1 Execution Services LLC
20,917
0.22%
20,917
0%
06/30/2018
Fiera Capital Corp. (Investment Management)
18,333
0.19%
18,333
0%
06/30/2018
Barclays Capital, Inc.
10,051
0.11%
-17,462
0%
06/30/2018

About Jaguar Animal Health

View Profile
Address
201 Mission Street
San Francisco California 94105
United States
Employees -
Website http://www.jaguar.health
Updated 07/08/2019
Jaguar Health, Inc. engages in the dvelopment of gastrointestinal products for both human prescription use and animals. Its products include Mytesi, Canalevia, Equilevia, and Neonorm. The Mytesi product IS use for relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.